UBS Group’s HumanCo Acquisition Corp. Unit HMCOU Stock Holding History

UBS Group’s Portfolio HMCOU Stock Details HMCOU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,162	Closed	-$211K	–	11771
2022 Q3	$211K	Hold	21,162	–	–	﹤0.01%	5038
2022 Q2	$209K	Sell	21,162 -169	-0.8%	-$1.68K	﹤0.01%	4876
2022 Q1	$213K	Hold	21,331	–	–	﹤0.01%	5307
2021 Q4	$216K	Sell	21,331 -298	-1%	-$3.08K	﹤0.01%	5621
2021 Q3	$221K	Buy	21,629 +772	+4%	+$7.89K	﹤0.01%	5239
2021 Q2	$216K	Buy	20,857 +2,523	+14%	+$26.3K	﹤0.01%	5288
2021 Q1	$193K	Sell	18,334 -1,666	-8%	-$19.1K	﹤0.01%	5520
2020 Q4	$220K	Buy	+20,000	New	+$222K	﹤0.01%	5186

UBS Group's HMCOU Position: Q4 2022 in Review

UBS Group sold out of HumanCo Acquisition Corp. Unit (HMCOU) in Q4 2022, closing a stake of 21,162 shares — an estimated $211K sold.

UBS Group first reported a position in HMCOU in Q4 2020 and held it in 8 quarters. The position peaked at $221K in Q3 2021. 0 funds tracked by Wall St. Rank hold HMCOU as of Q4 2022.

UBS Group reported no remaining HumanCo Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
UBS Group sold 21,162 HumanCo Acquisition Corp. Unit shares in Q4 2022, an estimated $211K.
UBS Group first reported a position in HumanCo Acquisition Corp. Unit in Q4 2020 and held it in 8 quarters.
UBS Group's HumanCo Acquisition Corp. Unit position peaked at $221K in Q3 2021.
0 funds tracked by Wall St. Rank held HumanCo Acquisition Corp. Unit as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.